Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

CHART Thread, page-1743

First 1743 Last

Share
Profile

Follow
Driver1

500 Posts.

73

27/01/22

20:10

Post #: 59172166
Share

Originally posted by tradingformils: ↑

Greatest buying opportunity in history

NASDAQ may still fall, as Fed was ultra-hawkish yesterday. Powell said “Asset prices are somewhat elevated. They don’t now pose a threat to financial stability". Powell admitted that the Fed is “willing to move sooner” and “perhaps faster” than last time in shrinking the balance sheet.

That's freaking the market.

Who knows how low it will go and the correction will last?

But IHL's fundamentals remain in tact and extremely sound. With plenty of news around the corner (OSA, TBI, IHL-675A, RA, IBD and a potential 2nd psychedelics program), there's lots to look forward to for investors who can see further than their noses.

So, yes the share price could go lower, with the market panicking. But come 3-6 months, when the market is calmer and IHL's drug development program more advanced, the share price will probably be making new highs.

Screaming hot buying opportunity ahead of the loyalty options issue, where likely the more share you own, the more you'll get rewarded. That sounds like a pretty good deal if you think the drug development program will be more advanced in 3-6 months (and the share price higher), so just in time to attract coin from deep pocketed US investors and set to become the global market leader with plenty going on.

To your first million,
-Trading For Millions

Expand

That's it, fundamentals still intact, outside forces moving the sp at the moment, looking forward to the next 6 mths and beyond.

IHL Price at posting: 43.0¢ Sentiment: Hold Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement